---
title: "How Broad Russell Growth Index Additions At Andersons (ANDE) Have Changed Its Investment Story"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291897474.md"
description: "The Andersons, Inc. (ANDE) was added to multiple Russell growth indices on June 27, 2026, potentially broadening its investor base through passive fund adjustments. While this enhances liquidity and awareness, it does not fundamentally alter the company's near-term investment narrative, which remains tied to ethanol tax credits, carbon projects, and commodity-driven margin volatility. Q1 2026 earnings showed $2.63 billion in sales and $33.19 million in net income, highlighting continued dependence on policy support and market cycles."
datetime: "2026-07-07T08:06:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291897474.md)
  - [en](https://longbridge.com/en/news/291897474.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291897474.md)
---

# How Broad Russell Growth Index Additions At Andersons (ANDE) Have Changed Its Investment Story

-   On 27 June 2026, The Andersons, Inc. was added to multiple Russell growth benchmarks, including the Russell 2000 Growth, 2500 Growth, 3000 Growth, 3000E Growth, Small Cap Comp Growth, and 2000 Growth-Defensive indices.
-   This cluster of index inclusions can meaningfully broaden Andersons’ investor base as passive and benchmark-aware funds adjust their holdings to reflect the changes.
-   We’ll now examine how Andersons’ broad Russell growth index additions might reinforce or challenge the company’s existing ethanol-focused investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

## Andersons Investment Narrative Recap

To own Andersons today, you need to believe the company can translate its ethanol and grain platform into steadier earnings despite commodity and policy swings, while managing higher capital intensity and debt. The broad Russell growth index inclusions may support trading liquidity and awareness, but they do not fundamentally change the near term catalysts around ethanol tax credits and carbon projects, or the key risk from commodity driven margin volatility and policy dependence.

Among recent developments, the Q1 2026 earnings release stands out as most relevant beside the Russell additions, as it gives you a current snapshot of scale and profitability before new index driven flows potentially influence the shareholder mix. With US$2,627.27 million in quarterly sales and US$33.19 million in net income, it frames how dependent results still are on commodity cycles and renewables policy support, which remain central to both the upside case and the risk profile.

Yet behind the index news, investors should also be aware that earnings could be constrained if policy support or crush margins weaken and...

Read the full narrative on Andersons (it's free!)

Andersons' narrative projects $13.2 billion revenue and $291.3 million earnings by 2029.

Uncover how Andersons' forecasts yield a $80.00 fair value, a 19% upside to its current price.

## Exploring Other Perspectives

ANDE 1-Year Stock Price Chart

Contrast this with the lowest analysts, who see more risk that climate and digital disruption blunt the benefits of index inclusion, even if earnings reached about US$252.3 million on roughly US$12.2 billion of revenue by 2029.

Explore 2 other fair value estimates on Andersons - why the stock might be worth over 8x more than the current price!

## Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

-   A great starting point for your Andersons research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
-   Our free Andersons research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Andersons' overall financial health at a glance.

## Searching For A Fresh Perspective?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

-   AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
-   We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
-   Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

_This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

### **New:** Manage All Your Stock Portfolios in One Place

We've created the **ultimate portfolio companion** for stock investors, **and it's free.**

• Connect an unlimited number of Portfolios and see your total in one currency  
• Be alerted to new Warning Signs or Risks via email or mobile  
• Track the Fair Value of your stocks  

Try a Demo Portfolio for Free

### Related Stocks

- [ANDE.US](https://longbridge.com/en/quote/ANDE.US.md)

## Related News & Research

- [The Andersons, Inc. $ANDE Stake Raised by Inspire Investing LLC](https://longbridge.com/en/news/291258090.md)
- [Vita Hydrokultur Opens £1.5m Series A Round to Scale Plant-Grown Skincare Ingredients](https://longbridge.com/en/news/293883034.md)
- [12:34 ETTop 5 Gundry MD Polyphenol Dark Spot Diminisher Review: Where to Buy, What's Inside, and Does It Actually Work?](https://longbridge.com/en/news/294093544.md)
- [Alpha Cognition wins European patent covering Zunveyl ingredient for Alzheimer’s treatment](https://longbridge.com/en/news/294207847.md)
- [10:56 ETResearch Published in Mayo Clinic Proceedings: Digital Health Reveals Body Composition Predicts GLP-1 Weight Loss Outcomes](https://longbridge.com/en/news/294226323.md)